The European Medicines Agency (EMA) is collaborating with healthcare professional organisations and learned societies to develop a communication tool on vaccines.
'Vaccine Essentials’ is meant to help increase vaccine science literacy. It relies on vaccine science and regulation to address vaccine-related information gaps and concerns that healthcare professionals identify.
The first Vaccine Essentials topic focuses on meningococcal B vaccines, also known MenB vaccines. These vaccines help prevent the invasive meningococcal disease (IMD) caused by Meningococci B bacteria. It is a serious bacterial infection that can have life-changing consequences for children and young adults.
EMA and the European Academy of Paediatrics (EAP) co-created the information on this topic
For more details on EMA's work to communicate about vaccine-preventable diseases, see:
Vaccine Essentials aims to provide the following types of information:
A facts and figures document is available on meningococcal B (MenB) vaccines.
It provides an overview on the burden of disease that the Meningococci B bacteria causes. It includes data on key aspects like:
MenB vaccines illustrate how vaccines protect children from very severe disease. For more information, see EMA's scientific publication PubMed: Meningococcal B Vaccines as a Paradigm of Safe and Effective Vaccines for Children.
Vaccine Essentials complements other documents that EMA provides on specific vaccines, including the product information. This contains the approved conditions of use for a vaccine.
An update log is available to show the date and summary of changes to this webpage. It does not include updates to linked documents or minor edits like typos or broken link fixes.
26 March 2026
Page first published